# Lynozyfic (Linvoseltamab): A First‐in‐Class Off‐the‐Shelf T‐Cell Redirector for Refractory Multiple Myeloma

**Authors:** Raza Ur Rehman

PMC · DOI: 10.1002/jha2.70182 · 2025-11-20

## Full-text entities

- **Diseases:** Multiple Myeloma (MESH:D009101)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12631538/full.md

---
Source: https://tomesphere.com/paper/PMC12631538